419 related articles for article (PubMed ID: 36420692)
1. Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.
Rodolico A; Siafis S; Bighelli I; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014384. PubMed ID: 36420692
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia.
Bighelli I; Rodolico A; Siafis S; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014383. PubMed ID: 36042158
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders.
Ibragimov K; Keane GP; Carreño Glaría C; Cheng J; Llosa AE
Cochrane Database Syst Rev; 2024 Jul; 7():CD013425. PubMed ID: 38958149
[TBL] [Abstract][Full Text] [Related]
5. Cognitive behavioural therapy without medication for schizophrenia.
Bighelli I; Çıray O; Salahuddin NH; Leucht S
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD015332. PubMed ID: 38323679
[TBL] [Abstract][Full Text] [Related]
6. Maintenance treatment with antipsychotic drugs for schizophrenia.
Ceraso A; Lin JJ; Schneider-Thoma J; Siafis S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM; Leucht S
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD008016. PubMed ID: 32840872
[TBL] [Abstract][Full Text] [Related]
7. Cognitive behavioural therapy added to standard care for first-episode and recent-onset psychosis.
Mayer SF; Corcoran C; Kennedy L; Leucht S; Bighelli I
Cochrane Database Syst Rev; 2024 Mar; 3(3):CD015331. PubMed ID: 38470162
[TBL] [Abstract][Full Text] [Related]
8. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Weibel S; Rücker G; Eberhart LH; Pace NL; Hartl HM; Jordan OL; Mayer D; Riemer M; Schaefer MS; Raj D; Backhaus I; Helf A; Schlesinger T; Kienbaum P; Kranke P
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012859. PubMed ID: 33075160
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
Huang MW; Gibson RC; Jayaram MB; Caroff SN
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013100. PubMed ID: 35844143
[TBL] [Abstract][Full Text] [Related]
10. Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis.
Ostuzzi G; Vita G; Bertolini F; Tedeschi F; De Luca B; Gastaldon C; Nosé M; Papola D; Purgato M; Del Giovane C; Correll CU; Barbui C
Lancet Psychiatry; 2022 Aug; 9(8):614-624. PubMed ID: 35753323
[TBL] [Abstract][Full Text] [Related]
11. Wendan decoction (Traditional Chinese medicine) for schizophrenia.
Deng H; Xu J
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012217. PubMed ID: 28657646
[TBL] [Abstract][Full Text] [Related]
12. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.
Van Leeuwen E; van Driel ML; Horowitz MA; Kendrick T; Donald M; De Sutter AI; Robertson L; Christiaens T
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013495. PubMed ID: 33886130
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
14. Acupuncture for schizophrenia.
Shen X; Xia J; Adams CE
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005475. PubMed ID: 25330045
[TBL] [Abstract][Full Text] [Related]
15. Modafinil for people with schizophrenia or related disorders.
Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
[TBL] [Abstract][Full Text] [Related]
16. Risperidone (depot) for schizophrenia.
Sampson S; Hosalli P; Furtado VA; Davis JM
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological interventions for treatment-resistant depression in adults.
Davies P; Ijaz S; Williams CJ; Kessler D; Lewis G; Wiles N
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010557. PubMed ID: 31846068
[TBL] [Abstract][Full Text] [Related]
18. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
Dold M; Samara MT; Li C; Tardy M; Leucht S
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic combinations for schizophrenia.
Ortiz-Orendain J; Castiello-de Obeso S; Colunga-Lozano LE; Hu Y; Maayan N; Adams CE
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009005. PubMed ID: 28658515
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
